Socías ME, Ahamad K, Le Foll B, Lim R, Bruneau J, Fischer B, Wild C, Wood E, Justras-Aswad D The OPTIMA study, buprenorphine/naloxone and methadone models of care for the treatment of prescription opioid use disorder: study design and rationale Contemp Clin Trials, 2018. PubMed
Randhawa G, Azarbar A, Dong H, Milloy MJ, Kerr T, Hayashi K Childhood trauma and inability to access hospital care among people who inject drugs J Trauma Stress, 2018. PubMed
Bardwell G, Kerr T Drug checking: a potential solution to the opioid overdose epidemic? Subst Abuse Treat Prev Policy, 2018. PubMed
Kennedy MC, Kerr T, Wood E, Shoveller J, Montaner J, Milloy MJ Social and structural factors associated with greater time with a plasma HIV-1 RNA viral load above log10(1500) copies/ml among illicit drug users AIDS, 2018. PubMed
Ti L, Parent S, Socías ME Integrated models of care for people living with hepatitis C virus and a substance use disorder: protocol for a systematic review JMIR Res Protoc, 2018. PubMed
Klimas J, Nosova E, Socías ME, Nolan S, Brar R, Hayashi K, Milloy MJ, Kerr T, Wood E Factors associated with discontinuation of methadone maintenance therapy (MMT) among persons who use alcohol in Vancouver, Canada Drug Alcohol Depend, 2018. PubMed
Collins A, Boyd J, Damon W, Czechaczek S, Krüsi A, Cooper H, McNeil R Surviving the housing crisis: social violence and the production of evictions among women who use drugs in Vancouver, Canada Health Place, 2018. PubMed
Beaulieu T, Hayashi K, Milloy MJ, Nosova E, DeBeck K, Montaner J, Kerr T, Ti L HIV serostatus and having access to a physician for regular hepatitis C virus care among people who inject drugs J Acquir Immune Defic Syndr, 2018. PubMed
Collins AB, Bluthenthal RN, Boyd J, McNeil R Harnessing the language of overdose prevention to advance evidence-based responses to the opioid crisis Int J Drug Policy, 2018. PubMed
Bardwell G, Anderson S, Richardson L, Bird L, Lampkin H, Small W, McNeil R The perspectives of structurally vulnerable people who use drugs on volunteer stipends and work experiences provided through a drug user organization: opportunities and limitations Int J Drug Policy, 2018. PubMed

